All filters
Slidesets
Heterosexual Transmission of Subtype C HIV-1 Does Not Require Increase Replicative Capacity or Interferon-alpha Resistance - Z. Ende
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Conserved molecular signatures in gp120 are associated with the genetic bottleneck in SIV, SHIV, and HIV-1 transmission - M. Gonzalez
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
HIV Transmission in the US and fitness effects of drug-resistant viruses - Joel Wertheim, PhD
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Multiplexed sequencing of HIV-1 env as a measure of viral diversity in HIV-1 infected transmission pairs - E. El-Badry
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Applications of Next-Generation Sequencing for Identification of Transmitted HIV-1 - K. Brooks
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
New generation of nucleic acid testing assays for acute infections - Michele Owen, PhD
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Mechanisms by which anti-α4β7 integrin reduces mucosal transmission in SIV macaque model - S. Byrareddy
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Co-infection of HTLV-1 permits HIV-1 direct infection of female genital epithelium in vitro despite antiretroviral therapy: Implications for HIV-1 vaginal transmission - Y. Tang
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Early transmission steps - Thomas Hope, PhD
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Safety and pharmacokinetics of quick dissolving polymeric vaginal films delivering antiretroviral combinations for pre-exposure - P. Srinivasan
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Pre-Exposure Prophylaxis Modality Preferences among Men who Have Sex with Men - E. Hall
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Approved Regimens for Non ‐Cirrhotic Patients - Graham Foster, FRCP, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Approved Regimens for Cirrhotic Patients - Marina Berenguer
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Panel Debate - Rafael Esteban, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Next Generation Regimens - Joost Drenth, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Liver Cancer - Massimo Colombo, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Decompensated Cirrhosis - Thomas Berg, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
08_sarrazin
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
09_Arends
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
10_Sarrazin
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Viral Co‐Infection - Mark Nelson, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
11_Zeuzem
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Patients in the US - Fred Poordad, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Patients in Poland - Robert Flisiak, MD, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015